Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Drug Alert: CDSCO flags 56 formulations as Not of Standard Quality

Drug Alert: 41 Drug samples including Cipla's TOFAJAK tablets fail To Qualify CDSCO Test

Susmita Roy4 Jan 2025 6:00 PM IST

New Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged 41 medicine...

Eli Lilly Alzheimers drug rejected by EU regulator

Eli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen

Susmita Roy17 Dec 2024 6:00 PM IST

New Delhi: The pharmaceutical major Eli Lilly and Company (India) has got the go-ahead from the Subject Expert Committee (SEC) functional under the...

Drug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and Carbimazole

Susmita Roy6 Dec 2024 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed adverse...

Not a Nice Time For Dr Reddys? DTAB, CDSCO Recommends Stringent Restrictions on Nimesulide

Dr Reddys Laboratories gets CDSCO Panel Nod to import, market Tegoprazan for gastrointestinal diseases

Susmita Roy28 Nov 2024 6:00 PM IST

New Delhi: In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert Committee (SEC)...

Intas Gets CDSCO Panel Nod for Pertuzumab

Intas Pharma gest CDSCO panel nod to manufacture, market anticancer drug Enzalutamide tablet

Susmita Roy27 Nov 2024 5:30 PM IST

New Delhi: Intas Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...

Lupin unveils pregnancy prevention drug Minzoya in US

Revise protocol for Denosumab 60 mg prefilled syringe solution for injection: CDSCO Panel tells Lupin

Susmita Roy23 Nov 2024 5:30 PM IST

New Delhi: In line with the proposal presented by Lupin for conducting phase I study of Denosumab 60 mg prefilled syringe solution for injection (60...

CDSCO Panel nod to Torrent Gabapentin plus Duloxetine study

Torrent Pharmaceutical gets CDSCO Panel nod to study Gabapentin plus Duloxetine FDC

Susmita Roy12 Nov 2024 5:15 PM IST

New Delhi: Torrent Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...

Patients be informed of risks in self-administration: CDSCO Panel tells Takeda Biopharm on Agalsidase Alfa

Susmita Roy11 Nov 2024 6:00 PM IST

New Delhi: In line with the proposal presented by Takeda Biopharmaceuticals for an update in the package insert regarding home infusion for Agalsidase...

Alembic Pharma gets USFDA EIR for Panelav facility

USFDA proposes ban of Oral Phenylephrine as OTC for nasal congestion

Susmita Roy8 Nov 2024 6:00 PM IST

New Delhi: Following an agency review of the available data that found oral phenylephrine is ineffective for treating nasal congestion, the U.S. Food...

Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Tetracycline

Susmita Roy5 Oct 2024 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September, has revealed that the...

No Free Pass: CDSCO Mandates Registration, Import License for SEZ Drugs Sold in India

IRGMA Welcomes CDSCO's New Guidelines, Urges to stop import of substandard gloves

Susmita Roy30 Sept 2024 5:15 PM IST

New Delhi: Welcoming the updated guidelines detailing the functions and responsibilities of the zonal, sub-zonal, and port offices issued by the...

Revise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, Marketers

NPPA Revises and Fixes Ceiling Price of Chloroquine Tablet 150 mg

Susmita Roy15 Sept 2024 6:00 PM IST

New Delhi: Considering the wholesale price index (WPI) at 0.00551 percent, through a recent notification, the National Pharmaceutical Pricing...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok